As the Australian market faces a challenging period with futures indicating a dip and global trade tensions intensifying, investors are keenly observing how these factors might affect stock valuations. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for those looking to invest in fundamentally strong companies at potentially attractive prices.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Superloop (ASX:SLC) | A$3.35 | A$6.38 | 47.5% |
Ridley (ASX:RIC) | A$2.89 | A$5.78 | 50% |
PointsBet Holdings (ASX:PBH) | A$1.215 | A$2.10 | 42% |
Medical Developments International (ASX:MVP) | A$0.555 | A$1.07 | 48.1% |
Infomedia (ASX:IFM) | A$1.295 | A$2.07 | 37.3% |
Fenix Resources (ASX:FEX) | A$0.295 | A$0.49 | 40.1% |
Domino's Pizza Enterprises (ASX:DMP) | A$18.24 | A$29.70 | 38.6% |
Collins Foods (ASX:CKF) | A$9.29 | A$15.89 | 41.5% |
Charter Hall Group (ASX:CHC) | A$19.92 | A$35.43 | 43.8% |
Advanced Braking Technology (ASX:ABV) | A$0.093 | A$0.16 | 42.7% |
Click here to see the full list of 29 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Overview: ALS Limited provides professional technical services focused on testing, measurement, and inspection across regions including Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States with a market capitalization of A$9.16 billion.
Operations: The company's revenue is derived from two main segments: Commodities, contributing A$1.09 billion, and Life Sciences, accounting for A$1.91 billion.
Estimated Discount To Fair Value: 34.2%
ALS Limited is trading at A$18.06, significantly below its estimated fair value of A$27.44, highlighting its undervaluation based on discounted cash flow analysis. Despite a high level of debt, ALS's earnings are projected to grow 13.07% annually, surpassing the Australian market average. Recent capital raising efforts totaling A$390 million aim to support laboratory expansion and M&A activities while maintaining a focus on deleveraging and organic growth opportunities in the testing services sector.
Overview: Judo Capital Holdings Limited, with a market cap of A$1.74 billion, operates through its subsidiaries to provide a range of banking products and services tailored for small and medium businesses in Australia.
Operations: Judo Capital Holdings Limited generates revenue of A$325.50 million from its banking segment, focusing on services for small and medium enterprises in Australia.
Estimated Discount To Fair Value: 25.8%
Judo Capital Holdings is trading at A$1.56, below its estimated fair value of A$2.1, indicating undervaluation based on discounted cash flow analysis. Earnings are expected to grow significantly at 24.8% annually, outpacing the Australian market average of 10.7%. However, the forecasted Return on Equity remains low at 9.5%. Revenue growth is projected at 17.5% per year, faster than the market's 5.5%, but below a high-growth threshold of 20%.
Overview: Ridley Corporation Limited, with a market cap of A$1.08 billion, operates in Australia providing animal nutrition solutions through its subsidiaries.
Operations: The company's revenue is primarily derived from Bulk Stockfeeds at A$894.26 million and Packaged/Ingredients at A$389.70 million.
Estimated Discount To Fair Value: 50%
Ridley Corporation, trading at A$2.89, is significantly undervalued with a fair value estimate of A$5.78 based on discounted cash flow analysis. Revenue is projected to grow at 20.7% annually, surpassing the Australian market's average growth rate of 5.5%. Earnings are expected to increase by 16.6% per year, exceeding the market's 10.7%. However, its Return on Equity forecast is modest at 14.4%, and dividend stability remains uncertain amid recent equity and fixed-income offerings totaling A$175 million.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks
Try a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.